Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FNKVP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,512
Award facts
- Contract value 100% obligated
- $25,511.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (quantity: 90 units) under a firm fixed-price contract with a ceiling value of $25,511.50. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026.
The DLA's pharmaceutical procurement through AmerisourceBergen reflects the agency's reliance on established prime vendor relationships to supply critical medications to Defense Health Agency facilities and other federal healthcare systems globally. Jardiance, an antidiabetic medication, aligns with AmerisourceBergen's extensive portfolio of diabetes management pharmaceuticals provided to military healthcare programs. As a non-set-aside award, this delivery order demonstrates the contractor's competitive capability to fulfill federal medical supply requirements. The rapid completion timeline indicates an urgent or routine replenishment order within the broader pharmaceutical supply chain supporting DoD medical operations.
Quick answers
Who was awarded contract SPE2DB25FNKVP?
SPE2DB25FNKVP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FNKVP worth?
The government has obligated $25,512 on SPE2DB25FNKVP.
Is contract SPE2DB25FNKVP an order under another contract?
Yes. SPE2DB25FNKVP is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNKVP competed?
The extent of competition for SPE2DB25FNKVP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award